Apoptosis deregulation in myeloproliferative neoplasms.
Philadelphia-chromosome negative chronic myeloproliferative neoplasms are clonal hematologic diseases characterized by hematopoietic progenitor independence from or hypersensitivity to cytokines. The cellular and molecular mechanisms involved in the pathophysiology of myeloproliferative neoplasms have not yet been fully clarified. Pathophysiologic findings relevant for myeloproliferative neoplasms are associated with genetic alterations, such as, somatic mutation in the gene that codifies JAK-2 (JAK V617F). Deregulation of the process of programmed cellular death, called apoptosis, seems to participate in the pathogenesis of these disorders. It is known that expression deregulation of pro- and anti-apoptotic genes promotes cell resistance to apoptosis, culminating with the accumulation of myeloid cells and establishing neoplasms. This review will focus on the alterations in apoptosis regulation in myeloproliferative neoplasms, and the importance of a better understanding of this mechanism for the development of new therapies for these diseases.
Raquel
R
Tognon
Natália de Souza
Nde S
Nunes
Fabíola Attié de
FA
Castro
D017209:Apoptosis / Q000235:genetics*; D006801:Humans; D009154:Mutation / Q000235:genetics*; D054437:Myelodysplastic-Myeloproliferative Diseases / Q000235:genetics*